Name: PubCaseFinder
License: http://creativecommons.org/licenses/by/2.1/jp/
Keywords: PubCaseFinder,PCF,Rare Disease,Phenotype,Gene,Match,Assist

Dermatomyositis

A type of idiopathic inflammatory myopathy characterized by evocative skin lesions and symmetrical proximal muscle weakness.

Lymphoproliferative disorder

Total: 8

(per page)

PMID (PMCID)
19628340	MIXED_SAMPLE
	Methotrexate-associated lymphoproliferative disorders mimicking angioimmunoblastic T-cell lymphoma.
	Hatanaka K, Nakamura N, Kojima M, Ando K, Irie S, Bunno M, Nakamine H, Uekusa T. Pathol Res Pract. 2010;206(1):9-13.
	Patients affected by autoimmune diseases (rheumatoid arthritis (RA), psoriasis, and dermatomyositis) treated with methotrexate (MTX) develop lymphoproliferative disorders (LPDs).
20676828	FEMALE
	Methotrexate-related Epstein-Barr Virus (EBV)-associated lymphoproliferative disorder--so-called "Hodgkin-like lesion"--of the oral cavity in a patient with rheumatoid arthritis.
	Kikuchi K, Miyazaki Y, Tanaka A, Shigematu H, Kojima M, Sakashita H, Kusama K. Head Neck Pathol. 2010;4(4):305-11.
	Patients affected by autoimmune diseases (rheumatoid arthritis, psoriasis, dermatomyositis) who are treated with methotrexate (MTX) sometimes develop lymphoproliferative disorders (LPDs).
19027995	FEMALE	Adult
	[Cutaneous EBV-associated lymphoproliferative disorder in a dermatomyositis treated with immunosuppressive agents].
	Steff M, Le Corre Y, Penisson-Besnier I, Michalak S, Drossard G, Lebrun-Vignes B, Le Clec'h C. Rev Med Interne. 2009;30(8):720-3.
	This is the third case of immunosuppressive induced lymphoproliferative disorder localized to skin in a patient with dermatomyositis.
18589184	FEMALE
	Case report: successful treatment of posttransplant lymphoproliferative disorder and quiescence of dermatomyositis with rituximab and sirolimus.
	Kaposztas Z, Etheridge WB, Kahan BD. Transplant Proc. 2008;40(5):1744-6.
	Case report: successful treatment of posttransplant lymphoproliferative disorder and quiescence of dermatomyositis with rituximab and sirolimus.
15168153	MALE
	Dermatomyositis associated with lymphoproliferative disorder of NK cells and occult small cell lung carcinoma.
	Antonioli CM, Airo P. Clin Rheumatol. 2004;23(3):239-41.
	We report a case of dermatomyositis that was associated with a marked expansion of circulating NK cells (CD3-CD16+) with homogeneous phenotype (CD56- CD94- CD159a- CD244+) which satisfied the updated diagnostic criteria for the lymphoproliferative disorder of granular lymphocytes/NK cells.
12001001	FEMALE	Middle Aged
	Peripheral T cell lymphoma presenting as dermatomyositis-like eruption.
	Rencic A, Laman S, Nousari HC. J Cutan Med Surg. 2002;6(3):218-20.
	Although rare, a lymphoproliferative disorder must be included in the differential diagnosis of a cutaneous dermatomyositis-like eruption.
12001001	FEMALE	Middle Aged
	Peripheral T cell lymphoma presenting as dermatomyositis-like eruption.
	Rencic A, Laman S, Nousari HC. J Cutan Med Surg. 2002;6(3):218-20.
	There are several conditions reported to mimic the cutaneous manifestations of dermatomyositis, including lymphoproliferative disorders.
11499826	MIXED_SAMPLE	Middle Aged
	Cutaneous lymphoma associated with Epstein-Barr virus infection in 2 patients treated with methotrexate.
	Tournadre A, D'Incan M, Dubost JJ, Franck F, Dechelotte P, Souteyrand P, Soubrier M. Mayo Clin Proc. 2001;76(8):845-8.
	Discontinuation of methotrexate is necessary in patients with RA or dermatomyositis who have a lymphoproliferative disorder, and a follow-up period of several weeks should be observed before specific therapy is initiated.